0000950170-23-027743.txt : 20230613 0000950170-23-027743.hdr.sgml : 20230613 20230613165513 ACCESSION NUMBER: 0000950170-23-027743 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20230612 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20230613 DATE AS OF CHANGE: 20230613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bolt Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001641281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472804636 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39988 FILM NUMBER: 231011961 BUSINESS ADDRESS: STREET 1: 900 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-665-9295 MAIL ADDRESS: STREET 1: 900 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 FORMER COMPANY: FORMER CONFORMED NAME: Bolt Therapeutics, Inc. DATE OF NAME CHANGE: 20150504 8-K 1 bolt-20230612.htm 8-K 8-K
false000164128100016412812023-06-122023-06-12

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 12, 2023

 

 

BOLT BIOTHERAPEUTICS, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39988

47-2804636

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

900 Chesapeake Drive

 

Redwood City, California

 

94063

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (650) 665-9295

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.00001 per share

 

BOLT

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 12, 2023, Bolt Biotherapeutics, Inc. (the “Company”) held its 2023 annual meeting of stockholders (the “Annual Meeting”) to consider and vote on the two proposals set forth below, each of which is described in greater detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 28, 2023.

a.
The following director nominees were elected to serve as Class II members of the Company’s board of directors until the Company’s 2026 Annual Meeting of Stockholders, or until their respective successor is duly elected and qualified, or until their respective death, resignation or removal:

Nominee

 

Votes For

 

 

Votes Withheld

 

 

Broker Non-Votes

 

Randall C. Schatzman, Ph.D.

 

 

18,339,155

 

 

 

49,830

 

 

 

8,491,458

 

Edgar G. Engleman, M.D.

 

 

18,300,413

 

 

 

88,572

 

 

 

8,491,458

 

James I. Healy, M.D., Ph.D.

 

 

14,449,941

 

 

 

3,939,044

 

 

 

8,491,458

 
b.
The selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified.

Votes For

 

 

Votes Against

 

 

Votes Abstaining

 

 

26,831,426

 

 

 

33,439

 

 

 

15,578

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Bolt Biotherapeutics, Inc.

 

 

 

 

Date:

June 13, 2023

By:

/s/ William P. Quinn

 

 

 

William P. Quinn
Chief Financial Officer

 

 EX-101.LAB 2 bolt-20230612_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Securities Act File Number Entity Incorporation, State or Country Code Entity Information, Former Legal or Registered Name Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications EX-101.PRE 3 bolt-20230612_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 4 bolt-20230612.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information
Jun. 12, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 12, 2023
Entity Registrant Name BOLT BIOTHERAPEUTICS, INC.
Entity Central Index Key 0001641281
Entity Emerging Growth Company true
Securities Act File Number 001-39988
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 47-2804636
Entity Address, Address Line One 900 Chesapeake Drive
Entity Address, City or Town Redwood City
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94063
City Area Code (650)
Local Phone Number 665-9295
Entity Information, Former Legal or Registered Name Not Applicable
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period true
Title of 12(b) Security Common Stock, par value $0.00001 per share
Trading Symbol BOLT
Security Exchange Name NASDAQ
XML 6 bolt-20230612_htm.xml IDEA: XBRL DOCUMENT 0001641281 2023-06-12 2023-06-12 false 0001641281 8-K 2023-06-12 BOLT BIOTHERAPEUTICS, INC. DE 001-39988 47-2804636 900 Chesapeake Drive Redwood City CA 94063 (650) 665-9295 Not Applicable false false false false Common Stock, par value $0.00001 per share BOLT NASDAQ true true EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports bolt-20230612.htm bolt-20230612.xsd bolt-20230612_lab.xml bolt-20230612_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bolt-20230612.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 24 }, "contextCount": 1, "dts": { "inline": { "local": [ "bolt-20230612.htm" ] }, "labelLink": { "local": [ "bolt-20230612_lab.xml" ] }, "presentationLink": { "local": [ "bolt-20230612_pre.xml" ] }, "schema": { "local": [ "bolt-20230612.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "bolt", "nsuri": "http://boltbio.com/20230612", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "bolt-20230612.htm", "contextRef": "C_aa0f509b-d710-4a01-88df-e1ffd18cc933", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "bolt-20230612.htm", "contextRef": "C_aa0f509b-d710-4a01-88df-e1ffd18cc933", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://boltbio.com/20230612/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 13 0000950170-23-027743-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-23-027743-xbrl.zip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end